Literature DB >> 25314087

Progestins for contraception: modern delivery systems and novel formulations.

Pamela A Royer1, Kirtly P Jones.   

Abstract

Since the development of combined oral contraceptives over 50 years ago, significant innovations have occurred in the domain of the progestin. Evolving knowledge of progestin mechanism of action and physiology has allowed for development of novel progestins with limited steroid receptor cross-reactivity, decreased side effect profiles, and pharmacokinetics optimized for modern delivery systems. This review summarizes current knowledge of progestin physiology, modern delivery systems, and developments of progestin agonists and antagonists for contraception.

Mesh:

Substances:

Year:  2014        PMID: 25314087     DOI: 10.1097/GRF.0000000000000072

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  3 in total

1.  Estimating systemic exposure to levonorgestrel from an oral contraceptive.

Authors:  Cale N Basaraba; Carolyn L Westhoff; Malcolm C Pike; Renu Nandakumar; Serge Cremers
Journal:  Contraception       Date:  2016-12-30       Impact factor: 3.375

Review 2.  Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation.

Authors:  Ricardo Londono; Vijay S Gorantla; Stephen F Badylak
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

3.  Antiproliferative Properties of Newly Synthesized 19-Nortestosterone Analogs Without Substantial Androgenic Activity.

Authors:  András Gyovai; Renáta Minorics; Anita Kiss; Erzsébet Mernyák; Gyula Schneider; András Szekeres; Erika Kerekes; Imre Ocsovszki; István Zupkó
Journal:  Front Pharmacol       Date:  2018-07-27       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.